IBSS Logo.jpg
Intelligent Bio Solutions Plans to Add Fentanyl Testing as it Further Enhances its Fingerprint-Based Drug Screening Solution
16 mai 2023 07h30 HE | Intelligent Bio Solutions, Inc.
Lab-testing pathway to expand capabilities of proprietary drug test screening to detect potent opioid fentanyl and fentanyl-adulterated street drugs Opioid crisis estimated to be costing the U.S....
IBSS Logo.jpg
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights
11 mai 2023 17h19 HE | Intelligent Bio Solutions, Inc.
- Combined revenue and government support income increased 199% year-over-year - - Sequential revenue growth of 28% -- Filed 513(g) submission with U.S. FDA for Intelligent Fingerprinting Drug...
IBSS Logo.jpg
Intelligent Bio Solutions Scales Reach Throughout Asia-Pacific Region with Addition of Sales Team in Australia, New Distribution Hub and Office Facility
02 mai 2023 07h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) --  Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
IBSS Logo.jpg
UK Food Processing Equipment Manufacturer Latest to Adopt Intelligent Bio Solutions’ Portable Fingerprint Drug Testing Solution
26 avr. 2023 08h00 HE | Intelligent Bio Solutions, Inc.
“Having experienced urine drug testing myself, I know it’s not a pleasant experience for anyone. So, when it came to selecting a drug screening approach for Dodman, it was clear that fingerprint...
IBSS Logo.jpg
Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader
18 avr. 2023 07h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
IBSS Logo.jpg
A & F Sprinklers Selects Intelligent Bio Solutions’ Latest DSR-Plus Screening Unit to Support its Random Drug Screening Program
27 mars 2023 07h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), today announced that A & F Sprinklers, one of the UK’s leading fire...
IBSS Logo.jpg
Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia
13 mars 2023 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("Intelligent Bio Solutions" or the "Company") (Nasdaq: INBS), a life sciences company developing and delivering...
IBSS Logo.jpg
Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
10 mars 2023 16h01 HE | Intelligent Bio Solutions, Inc.
NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time...
IBSS Logo.jpg
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
08 mars 2023 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time...
IBSS Logo.jpg
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
07 mars 2023 16h07 HE | Intelligent Bio Solutions, Inc.
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time...